Literature DB >> 9482283

Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the "optical probe technique".

M Wartenberg1, J Hescheler, H Acker, H Diedershagen, H Sauer.   

Abstract

Multicell-mediated drug resistance is a major impediment for the effectiveness of chemotherapeutic approaches and has been shown to be a feature of many solid tumors. We used confocal laser scanning microscopy to evaluate the depth distribution of the fluorescent cytostatic drug doxorubicin (Dox) in two size classes of multicellular cancer spheroids (MCS) (psi150+/-50 microm and 350+/-50 microm). MCS (psi150+/-50 microm) solely consist of proliferating cells, whereas in MCS (psi350+/-50 microm) peripheral proliferating cell layers are followed in the depth of the tissue by drug resistant quiescent cell areas. A technique was developed which allows noninvasively to trace fluorescence distributions down to a depth of approximately 180 microm in living MCS. This was achieved by confocal radial recordings of the mean Dox fluorescence in 600 microm2 regions of interest (ROI), equidistantly spaced (10 microm) from the center of MCS towards their periphery. The resulting fluorescence intensity profiles were subsequently corrected for absorbtion and light scattering in the depth of the tissue by a convenient algorithm. A 10 min incubation of MCS (psi150+/-50 microm) with Dox (10 microM) led to a peripheral accumulation, after 2 h Dox was homogeneously distributed within the whole MCS. In contrast, after Dox treatment of MCS (psi350+/-50 microm) for 2 h, the drug was accumulated within the peripheral proliferating cell rim of 78+/-8 microm, whereas deeper, quiescent cell layers remained unstained. When MCS were incubated with verapamil, cyclosporin A, orthovanadate, and quinidine, which are known to reverse P-glycoprotein (Pgp)-mediated multidrug resistance (MDR), Dox accumulated also in deeper cell layers. Genistein and indometacin which reverse multidrug resistance mediated by the multidrug resistance-associated protein (MRP) were without effects. The optical probe technique proved to be well suited to study MDR in a living three dimensional tissue context.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482283     DOI: 10.1002/(sici)1097-0320(19980201)31:2<137::aid-cyto9>3.0.co;2-j

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  12 in total

1.  Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.

Authors:  H Sauer; J Günther; J Hescheler; M Wartenberg
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Quantitative determination of irinotecan and the metabolite SN-38 by nanoflow liquid chromatography-tandem mass spectrometry in different regions of multicellular tumor spheroids.

Authors:  Xin Liu; Amanda B Hummon
Journal:  J Am Soc Mass Spectrom       Date:  2015-01-21       Impact factor: 3.109

3.  A Bayesian approach to estimate the diffusion coefficient of Rhodamine 6G in breast cancer spheroids.

Authors:  Miad Boodaghi; Sarah Libring; Luis Solorio; Arezoo M Ardekani
Journal:  J Control Release       Date:  2021-10-09       Impact factor: 9.776

4.  Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy.

Authors:  Zhen Luo; Rohan Vijay Tikekar; Kiana Michelle Samadzadeh; Nitin Nitin
Journal:  J Biomed Opt       Date:  2012-10       Impact factor: 3.170

5.  Characterization of trabecular bone plate-rod microarchitecture using multirow detector CT and the tensor scale: Algorithms, validation, and applications to pilot human studies.

Authors:  Punam K Saha; Yinxiao Liu; Cheng Chen; Dakai Jin; Elena M Letuchy; Ziyue Xu; Ryan E Amelon; Trudy L Burns; James C Torner; Steven M Levy; Chadi A Calarge
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

6.  The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.

Authors:  Can Sarisozen; Abraham H Abouzeid; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2014-07-10       Impact factor: 5.571

7.  The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.

Authors:  Kenny Chitcholtan; Peter H Sykes; John J Evans
Journal:  J Transl Med       Date:  2012-03-06       Impact factor: 5.531

8.  Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields.

Authors:  H Sauer; V Pütz; K Fischer; J Hescheler; M Wartenberg
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

9.  The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models.

Authors:  C Martin; J Walker; A Rothnie; R Callaghan
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

10.  Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.

Authors:  Wei-liang Ye; Yi-pu Zhao; Huai-qiu Li; Ren Na; Fei Li; Qi-bing Mei; Ming-gao Zhao; Si-yuan Zhou
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.